Can the FDA Help Reduce Drug Prices or the Cost of Medical Care?

• Autores: Diana M. Zuckerman
• Localización: American journal of public health, ISSN 0090-0036, Vol. 107, Nº. 11, 2017, págs. 1752-1754
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The author presents her thoughts on policies from U.S. Food and Drug Administration (FDA) commissioner Scott Gottlieb on reducing drug prices and medical care costs. Topics covered include generic drug laws, the effects of competition in the pharmaceutical industry, and FDA drug approval practices.